









Markets
/
Stocks
/
nasdaq-mmsi
/

Merit Medical Systems Inc

MMSI

68.730USD

-0.580-0.84%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

2.89BMarket Cap

31.64P/E TTM



Merit Medical Systems Inc

68.730

-0.580-0.84%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Merit Medical Systems Inc

Currency: USD Updated: 2026-03-27

Key Insights

Merit Medical Systems Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 102.50.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Merit Medical Systems Inc's Score

Industry at a Glance

Industry Ranking

25 / 208

Overall Ranking

105 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Merit Medical Systems Inc Highlights

StrengthsRisks

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 20.56% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 1.52B.

Undervalued

The company’s latest PE is 31.64, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 62.75M shares, decreasing 7.07% quarter-over-quarter.

Held by ETHSX

Star Investor ETHSX holds 5.11K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.08.

Analyst Rating

Based on 12 analysts

Buy

Current Rating

102.500

Target Price

+51.74%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Merit Medical Systems Inc is 8.42, ranking 34 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 393.94M, representing a year-over-year increase of 10.92%, while its net profit experienced a year-over-year increase of 35.99%.

Score

Industry at a Glance

Previous score

8.42

Change



Financials

9.15

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.24

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.52

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.89

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.28

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Merit Medical Systems Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Merit Medical Systems Inc is 3.90, ranking 198 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 31.64, which is 81.22% below the recent high of 57.35 and 2.94% above the recent low of 30.71.

Score

Industry at a Glance

Previous score

3.90

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 25/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Merit Medical Systems Inc is 8.50, ranking 24 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 104.00, with a high of 122.00 and a low of 90.00.

Score

Industry at a Glance

Previous score

8.50

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 12 analysts

Buy

Current Rating

102.500

Target Price

+51.74%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Merit Medical Systems Inc

MMSI

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Merit Medical Systems Inc is 6.84, ranking 57 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 75.15 and the support level at 64.33, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.93

Change

-0.09

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.589

Neutral

RSI(14)

37.892

Neutral

STOCH(KDJ)(9,3,3)

42.705

Buy

ATR(14)

2.222

Low Volatility

CCI(14)

-13.238

Neutral

Williams %R

62.787

Sell

TRIX(12,20)

-0.645

Sell

StochRSI(14)

79.757

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

68.366

Buy

MA10

68.454

Buy

MA20

70.299

Sell

MA50

76.823

Sell

MA100

81.758

Sell

MA200

84.294

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Merit Medical Systems Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 105.84%, representing a quarter-over-quarter decrease of 2.39%. The largest institutional shareholder is The Vanguard, holding a total of 6.57M shares, representing 11.05% of shares outstanding, with 0.42% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

7.91M

-0.78%

The Vanguard Group, Inc.

Star Investors

6.63M

-2.73%

State Street Investment Management (US)

2.20M

-0.89%

Conestoga Capital Advisors, LLC

2.19M

-1.19%

Fuller & Thaler Asset Management Inc.

1.84M

+1.30%

Geode Capital Management, L.L.C.

1.45M

+1.01%

Wellington Management Company, LLP

1.24M

+377.70%

Dimensional Fund Advisors, L.P.

1.18M

+6.19%

Nomura Investment Management Business Trust

1.33M

-8.57%

Citadel Advisors LLC

1.18M

-12.77%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Merit Medical Systems Inc is 8.77, ranking 18 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.64. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Merit Medical Systems Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.